Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Dec 9, 2020 (6 years ago)

Hydroxyzine Hydrochloride Oral Solution

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Impurities/Degradation Specification: OOS for the following - unknown degradant/impurity, 4-chorobenzophenone, and for total impurities.

Cause type: Impurity / degradation

An impurity or degradation product above its limit - other than nitrosamines. Unexpected substances in a batch can make it unsafe or less effective, even when the active ingredient is present. All impurity / degradation recalls.

What was recalled

Hydroxyzine Hydrochloride Oral Solution, USP (Syrup), 10 mg/5 mL, packaged in a) 4 fl oz (118 mL) bottle, NDC 60432-150-04, b) 1 pint (473 mL), NDC 60432-150-16, Rx Only, Manufactured By: Morton Grove Pharmaceuticals, Inc., Morton Grove, IL 60053

Affected NDCs 60432-0150-04 60432-0150-16

Compare with the code on your package — it is the most precise check available.

Drug: Hydroxyzine

Recalling firm
Morton Grove Pharmaceuticals, Inc.
NDC code
60432-150-04
Origin
IL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0174-2021 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Hydroxyzine recalls

See all
Class II · Moderate risk

HydrOXYzine HYDROCHLORIDE SYRUP

CGMP Deviations: cleaning procedures during manufacturing caused out of specification results for unknown impurities.

Terminated Impurity / degradation Lannett Company, Inc. NDC 54838-502-80 D-0083-2019

Other recalls by Morton Grove Pharmaceuticals, Inc.

All 2020 recalls
Class II · Moderate risk

Dexamethasone Elixir

Failed Impurities/Degradation Specifications: higher than permissible levels of unknown impurities were found in the drug product.

Terminated Impurity / degradation Morton Grove Pharmaceuticals, Inc. NDC 60432-466-08 D-0713-2022
Class II · Moderate risk

Valproic Acid Oral Solution USP

CGMP Deviations: Potential concern with products manufactured using liquid sugar batches contaminated with microbial organisms.

Completed Microbial contamination Morton Grove Pharmaceuticals, Inc. D-0816-2021
Class II · Moderate risk

Promethazine Syrup Plain

CGMP Deviations: Potential concern with products manufactured using liquid sugar batches contaminated with microbial organisms.

Completed Microbial contamination Morton Grove Pharmaceuticals, Inc. D-0814-2021